CEimpact

The Siderophore that Can Do More

Overview / Abstract:	Antimicrobial resistance is a top public health concern globally. Cefiderocol, a recently approved siderophore cephalosporin antimicrobial, will be evaluated using a case series and literature review. Join us to learn when to use the newest cephalosporin in patient care.
Expiration	Nov 11, 2023
Discipline(s)	Pharmacy CPE
Format	Online, Webinar / Webcast / Video
Cost	$9.00
Credits / Hours	0.10
Accreditation	ACPE
Presenters / Authors / Faculty	Christina Rivera, PharmD, BCPS, AAHIV-P Pharmacist Mayo Clinic Rochester
Keywords / Search Terms	CEimpact CEI Impact live, infectious disease, new drug, journal club, trial, clinical trial, journal, mcephalosporins and related products, november journal club

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map